A nomogram to predict the risk of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in Cirrhotic Patients.

Scientific Reports
Xiaochun YinYuzheng Zhuge

Abstract

Hepatic encephalopathy (HE) is a serious complication of decompensated liver cirrhosis, affecting the prognosis of patients underwent transjugular intrahepatic portosystemic shunts (TIPS). We aim to create a nomogram to predict hepatic encephalopathy- free survivals (HEFS) after TIPS in cirrhotic patients and select appropriate candidates for TIPS. Cirrhotic patients underwent TIPS from 2015 to 2018 in our department were included. Multivariable Cox regression was conducted to estimate the predictors of overt HE (OHE) after TIPS within one year. A nomogram based on the Cox proportional hazard model using data from a retrospective training cohort (70% of the patients) was developed. Then the prediction model was validated in the remaining 30% patients by Harrell's C-indexes, ROC curves and calibration plots. Of 373 patients, 117 developed postoperative OHE (31.4%). The training and validation groups comprised 83 (31.4%) and 34 (31.2%) patients, respectively. The cumulative survival rates of patients with HE at 1, 2 and 3 years were 90%, 83% and 76%, respectively. The nomogram included the following variables: age, Child-Turcotte-Pugh class (CTP class), diabetes mellitus (DM), serum creatinine and serum sodium (C-index = 0.772). ...Continue Reading

References

Mar 25, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·M MalinchocP C ter Borg
Mar 1, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Peter FerenciAndres T Blei
Sep 15, 2005·Cellular and Molecular Life Sciences : CMLS·D Shawcross, R Jalan
Sep 14, 2007·Scandinavian Journal of Gastroenterology·Evangelos Kalaitzakis, Einar Björnsson
Aug 2, 2008·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Pere Ginès, Mónica Guevara
Aug 20, 2008·Annals of Internal Medicine·David A Grimes
May 31, 2012·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Maria StepanovaZobair M Younossi
Nov 28, 2012·Metabolic Brain Disease·Javier AmpueroManuel Romero-Gómez
Mar 9, 2013·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Piero AmodioMarsha Y Morgan
Jul 22, 2014·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Hendrik VilstrupPhilip Wong
Jan 10, 2018·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jacqueline G O'LearyJasmohan S Bajaj
Jun 13, 2018·Journal of Clinical and Experimental Hepatology·Abhijith BaleAnurag Shetty
Oct 6, 2018·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Silvia NardelliOliviero Riggio
Feb 16, 2019·Journal of Clinical and Experimental Hepatology·Christopher R Flud, Andres Duarte-Rojo
Aug 8, 2019·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alberto Carmona-BayonasRocío García-Carbonero

❮ Previous
Next ❯

Citations

Nov 27, 2020·Journal of Clinical Medicine·Philipp SchindlerMoritz Wildgruber

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy

Software Mentioned

pROC
SPSS
R

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.